1.000000
0.000000
0.000000
0.000000
1.000000
0.000000
0.000000
0.000000
1.000000
0.00000
0.00000
0.00000
Spyroulias, G.A.
Nikolakopoulou, P.
Tzakos, A.
Gerothanassis, I.P.
Magafa, V.
Manessi-Zoupa, E.
Cordopatis, P.
http://mmcif.pdb.org/dictionaries/ascii/mmcif_pdbx.dic
C6 H15 N4 O2 1
175.209
y
ARGININE
L-peptide linking
C4 H7 N O4
133.103
y
ASPARTIC ACID
L-peptide linking
C6 H10 N3 O2 1
156.162
y
HISTIDINE
L-peptide linking
C6 H13 N O2
131.173
y
ISOLEUCINE
L-peptide linking
C6 H13 N O2
131.173
y
LEUCINE
L-peptide linking
C9 H11 N O2
165.189
y
PHENYLALANINE
L-peptide linking
C5 H9 N O2
115.130
y
PROLINE
L-peptide linking
C9 H11 N O3
181.189
y
TYROSINE
L-peptide linking
C5 H11 N O2
117.146
y
VALINE
L-peptide linking
IX
Eur.J.Biochem.
EJBCAI
0262
0014-2956
270
2163
2173
10.1046/j.1432-1033.2003.03573.x
12752436
Comparison of the solution structures of angiotensin I & II. Implication for structure-function relationship.
2003
US
J.Biol.Chem.
JBCHA3
0071
0021-9258
269
5303
5312
Role of the NH2-terminal domain of angiotensin II (ANG II) and [Sar1]angiotensin II
on conformation and activity. NMR evidence for aromatic ring clustering and peptide backbone
folding compared with [des-1,2,3]angiotensin II
1994
1.000000
0.000000
0.000000
0.000000
1.000000
0.000000
0.000000
0.000000
1.000000
0.00000
0.00000
0.00000
1
1299.499
Angiotensin I
1
syn
polymer
Ang I
no
no
DRVYIHPFHL
DRVYIHPFHL
A
polypeptide(L)
n
n
n
n
n
n
n
n
n
n
repository
Initial release
Version format compliance
Version format compliance
Structure summary
1
0
2003-07-29
1
1
2008-04-28
1
2
2011-07-13
1
3
2016-12-21
RCSB
Y
RCSB
2002-11-26
REL
THE PEPTIDE WAS made through Solid phase synthesis using Fmoc chemistry. THE SEQUENCE OF THE PEPTIDE IS NATURALLY FOUND IN homo sapiens.
sample
This structure was determined using standard 2D homonuclear techniques.
Models 1-20 are the family ensemble, while model 21 is the minimized
average structure derived from that ensemble.
target function for models 1-20, mean energy minimized for model 21
300
21
DQF-COSY
2D TOCSY
2D NOESY
ambient
298
K
This structure is based on a 225 NOE-derived distance constraints, 7 dihedral angle restraints, 1 distance restraint from hydrogen bond
simulated annealing, torsion angle dynamics
21
2.5 mM; DMSO-d6
DMSO-d6
collection
XWINNMR
2.6
processing
XWINNMR
2.6
Tai-he Xia, Christian Bartels, Kurt Wuthtrich
data analysis
XEASY
1.3
Peter Guntert, Christian Mumenthaler, Kurt Wuthrich
structure solution
DYANA
1.5
KOLLMAN, CASE, MERZ, CHEATHAM, SIMMERLING, DARDEN, PEARLMAN
refinement
AMBER
5.0
400
Bruker
DPX
ASP
1
n
1
ASP
1
A
ARG
2
n
2
ARG
2
A
VAL
3
n
3
VAL
3
A
TYR
4
n
4
TYR
4
A
ILE
5
n
5
ILE
5
A
HIS
6
n
6
HIS
6
A
PRO
7
n
7
PRO
7
A
PHE
8
n
8
PHE
8
A
HIS
9
n
9
HIS
9
A
LEU
10
n
10
LEU
10
A
author_defined_assembly
1
monomeric
1.0000000000
0.0000000000
0.0000000000
0.0000000000
1.0000000000
0.0000000000
0.0000000000
0.0000000000
1.0000000000
1_555
x,y,z
identity operation
0.0000000000
0.0000000000
0.0000000000
14
A
ARG
2
0.097
SIDE CHAIN
1
A
PHE
8
-171.75
117.36
1
A
HIS
9
-149.53
58.75
2
A
PHE
8
-171.58
118.30
2
A
HIS
9
-146.96
56.59
3
A
PHE
8
-171.58
118.30
3
A
HIS
9
-146.96
56.59
4
A
PHE
8
-171.72
119.30
4
A
HIS
9
-151.55
64.97
5
A
PHE
8
-171.89
117.86
6
A
PHE
8
-171.07
118.93
6
A
HIS
9
-148.27
58.33
7
A
PHE
8
-172.11
119.21
7
A
HIS
9
-148.35
59.63
8
A
PHE
8
-170.91
117.84
8
A
HIS
9
-151.10
65.66
9
A
PHE
8
-171.91
118.31
10
A
PHE
8
-170.43
119.85
11
A
PHE
8
-171.77
118.80
12
A
PHE
8
-171.48
120.14
13
A
PHE
8
-172.61
118.31
14
A
PHE
8
-171.25
119.07
14
A
HIS
9
-151.60
58.30
15
A
PHE
8
-171.72
117.20
16
A
PHE
8
-171.92
117.45
16
A
HIS
9
-151.34
63.70
17
A
PHE
8
-171.81
119.55
17
A
HIS
9
-153.46
61.79
18
A
PHE
8
-172.14
119.22
18
A
HIS
9
-149.75
57.10
19
A
PHE
8
-171.24
118.47
19
A
HIS
9
-150.37
63.29
20
A
PHE
8
-170.95
115.71
20
A
HIS
9
-153.52
35.98
21
A
PHE
8
-170.23
122.61
21
A
HIS
9
-153.61
59.70
Angiotensin I
Differences and Similarities in Solution Structures of Angiotensin I & II: Implication for Structure-Function Relationship
1
N
N
SIGNALING PROTEIN
Angiotensin, Renin-Angiotensin System, Solid Phase Peptide Synthesis, NMR Solution Structure, Peptides, SIGNALING PROTEIN
ANGT_HUMAN
UNP
1
34
P01019
DRVYIHPFHL
34
43
1N9U
1
10
P01019
A
1
1
10